Company”) would like to submit the Management Discussion and Analysis of the Company’s operation for the three-month period ended 30 June, 2019 with details as follows: Unit: Million Baht Consolidat ed

by Baht 2,095.88 million or 2.1 percent from Baht 101,251.90 million as at December 31, 2018. The details were as follows: (Million Baht) Jun 30, 2019 Dec 31, 2018 Increase (Decrease) % Current assets

6M18. Net profit rose 87.50% to Baht 83.14 million from Baht 44.34 million in 6M18, with net profit margin at 19.56% in 6M19 compared to 15.36% in 6M18. Details of the management discussion and analysis

for loss of production cost which increased comparing to the compensation of Baht 8.19 million of 2nd quarter of year 2018. DEMCO Public Company Limited Details of the costs involving to the WTGs

continue to focus on sales and cost to generate sustainable profit and to satisfy our shareholders as in the Company’s Turnaround roadmap. We are able to provide details as follow. Revenue Sales revenue for

Acts of Listed Companies concerning the Connected Transactions, B.E. 2546 (2003), dated November 15, 2003 and its amendments. 3. The details of Asset and Acquisition of Assets. Wattanapat Samui Hospital

in the regulations. The details of transaction are as follows: 1. Transaction date: Within Q2, 2018. 2. The parties involved: Buyer: Indorama Netherlands B.V. an indirect subsidiary of Indorama

and other shareholders as the shareholders of SRT and GCT, the determination of details of memorandum of association and articles of association of the New Company, the appointment of directors and

Dental Public Company Limited (LDC) would like to clarify the performance of the Company for the 3 months period ended March 31, 2018 which the details are as followed: Summary of the Company’s Performance

Limited would like to clarify the operating results of the Company. For the first quarter ending March 31st, 2018 the details are as follows: Comparison of operating results for the first quarter ending